Tyrosine Kinase Inhibitors Induced Thyroid Dysfunction: A Review of Its Incidence, Pathophysiology, Clinical Relevance, and Treatment

Tyrosine kinase inhibitors (TKI) belong to a new class of molecular multitargeted anticancer therapy which targets different growth factor receptors and hence attenuates cancer cell survival and growth. Since their introduction as adjunct treatment for renal cell carcinoma and gastrointestinal strom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadieh, Hala, Salti, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824811/
https://www.ncbi.nlm.nih.gov/pubmed/24282820
http://dx.doi.org/10.1155/2013/725410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824811/
https://www.ncbi.nlm.nih.gov/pubmed/24282820
http://dx.doi.org/10.1155/2013/725410

Ejemplares similares